2m 2m 2m 2m 2m 2m 2m
GH RSRCH (GHRS)
NASDAQ
$23.14-$0.47 (-1.99%)
Price as of Jun 23, 2026 7:52 PM EDT- $1.4BMarket Cap
- 89.13%1-Year Change
- BiotechnologyIndustry
GH RSRCH (GHRS)
$23.14-$0.47 (-1.99%)
GHRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.61 | ||
Change | -$0.15 (-0.67%) | ||
Open | $21.75 | ||
High | $24.36 | ||
Low | $21.26 | ||
Previous Close | $22.09 | ||
Volume | 308,091 | ||
30-Day Average Volume | 285,278 | ||
1-Week Change | 8.44% | ||
1-Month Change | -0.14% | ||
1-Year Change | 89.13% | ||
3-Year Change | 76.23% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 62.0M | ||
Total Assets | $288.2M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue